Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
Biohaven
BHVN
$2.13B
| $191K | ﹤0.01% |
14,300
-94,861
| -87% | -$1.37M |
2026 Q1
2 quarters
|
|
4052
Enovis
ENOV
$1.59B
| $189K | ﹤0.01% |
+10,367
| New | +$247K |
2026 Q3
0 quarters
|
|
4053
Navitas Semiconductor
NVTS
$2.58B
| $189K | ﹤0.01% |
+16,299
| New | +$201K |
2026 Q3
0 quarters
|
|
4054
Cognyte Software
CGNT
$619M
| $189K | ﹤0.01% |
+21,736
| New | +$190K |
2026 Q3
0 quarters
|
|
4055
Century Therapeutics
IPSC
$295M
| $189K | ﹤0.01% |
110,398
+20,249
| +22% | +$41.5K |
2026 Q1
2 quarters
|
|
4056
AMC Global Media
AMCX
$384M
| $189K | ﹤0.01% |
16,183
-98,128
| -86% | -$1.12M |
2025 Q3
4 quarters
|
|
4057
Precision BioSciences
DTIL
$307M
| $188K | ﹤0.01% |
30,064
-107,042
| -78% | -$809K |
2026 Q1
2 quarters
|
|
4058
Heron Therapeutics
HRTX
$62M
| $188K | ﹤0.01% |
600,287
+279,110
| +87% | +$106K |
2025 Q2
5 quarters
|
|
4059
CALL
Venture Global Inc
VG
$33.4B
| $187K | ﹤0.01% |
+14,800
| New | +$202K |
2026 Q3
0 quarters
|
|
4060
Broadstone Net Lease
BNL
$3.36B
| $186K | ﹤0.01% |
+10,055
| New | +$211K |
2026 Q3
0 quarters
|
|
4061
Cedar Fair
FUN
$1.14B
| $184K | ﹤0.01% |
+17,212
| New | +$277K |
2026 Q3
0 quarters
|
|
4062
CALL
FuelCell Energy
FCEL
$820M
| $184K | ﹤0.01% |
11,200
-68,300
| -86% | -$1.34M |
2026 Q2
1 quarter
|
|
4063
Definitive Healthcare
DH
$134M
| $184K | ﹤0.01% |
203,073
-148,502
| -42% | -$122K |
2026 Q1
2 quarters
|
|
4064
Canada Goose Holdings
GOOS
$780M
| $182K | ﹤0.01% |
23,406
-15,206
| -39% | -$131K |
2026 Q2
1 quarter
|
|
4065
Columbia Financial
CLBK
$3.02B
| $182K | ﹤0.01% |
16,458
-130,451
| -89% | -$1.44M |
2025 Q1
6 quarters
|
|
4066
Valens Semiconductor
VLN
$156M
| $182K | ﹤0.01% |
96,767
+51,129
| +112% | +$91.3K |
2025 Q3
4 quarters
|
|
4067
Real REMAX Group Inc. Common Stock
REAX
$406M
| $181K | ﹤0.01% |
11,064
-51,883
| -82% | -$1.05M |
2024 Q3
8 quarters
|
|
4068
Design Therapeutics
DSGN
$678M
| $181K | ﹤0.01% |
14,393
-15,237
| -51% | -$211K |
2025 Q4
3 quarters
|
|
4069
Oportun Financial
OPRT
$542M
| $181K | ﹤0.01% |
22,206
+2,604
| +13% | +$18.2K |
2026 Q2
1 quarter
|
|
4070
CALL
Bitdeer Technologies
BTDR
$1.69B
| $180K | ﹤0.01% |
+17,200
| New | +$196K |
2026 Q3
0 quarters
|
|
4071
American Well
AMWL
$207M
| $179K | ﹤0.01% |
+13,184
| New | +$158K |
2026 Q3
0 quarters
|
|
4072
Village Farms International
VFF
$311M
| $178K | ﹤0.01% |
61,315
-27,291
| -31% | -$67.3K |
2025 Q4
3 quarters
|
|
4073
PUT
Ondas Inc
ONDS
$3.1B
| $177K | ﹤0.01% |
24,100
-84,400
| -78% | -$664K |
2026 Q1
2 quarters
|
|
4074
PUT
Joby Aviation
JOBY
$5.43B
| $176K | ﹤0.01% |
29,100
+12,200
| +72% | +$88.6K |
2025 Q3
4 quarters
|
|
4075
Pennant Park Investment Corp
PNNT
$212M
| $176K | ﹤0.01% |
53,264
+3,724
| +8% | +$13.1K |
2026 Q2
1 quarter
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.